EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preclinical signal for a disease‐modifying effect on seizure cluster severity with intermittent diazepam treatment

Qian Wu iD, Michelle Guignet iD, Jonathan Vuong, H Steve White iD, Wesley T Kerr iD, Evelyn K Shih iD, Leock Y Ngo iD, Enrique Carrazana iD, Adrian L Rabinowicz iD

Epilepsia · 2026

DOI: 10.1002/epi.70051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Qian Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Center for Epilepsy Drug Discovery, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Diazepam, Anticonvulsants, Seizures, Status Epilepticus. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Neurelis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In epilepsy, daily treatment provides only symptomatic seizure control, leaving a significant unmet need for a treatment that affects the underlying predisposition to seizures. Here, in a first‐of‐its‐kind study, we test the hypothesis that intermittent treatment of seizure clusters with diazepam in the kainic acid post‐status epilepticus rat model of acquired epilepsy has an enduring effect on the seizure cluster phenotype, suggestive of potential disease modification.

Methods

Following kainic acid‐induced status epilepticus, rats with epilepsy were monitored for occurrence of seizure clusters (≥2 seizures in 24 h) for a 3‐week baseline period before entering a 6‐week treatment period using a previously established multidose regimen of diazepam ( n = 7) or vehicle ( n = 9) upon identification of a seizure cluster. In a subsequent 2‐week outcome period during which no rats received diazepam, we evaluated changes in seizure cluster size, burden (cluster size × severity), duration, and other phenotype parameters.

Results

A total of 3396 seizures and 216 seizure clusters were included for analysis. During the outcome period, time between seizures in a cluster (also interseizure interval [ISI]) was significantly longer in the diazepam group (log ISI = .25 longer, SE = .08, p < .0001), and the proportion of clustered seizures with an ISI of ≤30 min increased in the outcome period in the vehicle group ( p = .023) but was stable in the diazepam group. Despite the occurrence of rebound seizures during the treatment period, improvement in several phenotypical parameters, including severity and proportion of seizures in a cluster, supported a positive impact of intermittent diazepam treatment on seizure cluster biology. Significance Changes in several seizure cluster phenotypical parameters were suggestive of an enduring disease‐modifying effect of diazepam, despite an apparent rebound effect of intermittent diazepam treatment on seizure frequency. Further study is warranted using a model incorporating a background antiseizure medication regimen to potentially attenuate the unexpected rebound seizures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiazepamAnticonvulsantsSeizuresStatus EpilepticusAnimalsRatsMaleKainic AcidDisease Models, AnimalRats, Sprague-DawleySeverity of Illness Index

Stichwörter der Autor:innen

benzodiazepinedisease‐modifying effectimmediate‐use seizure medicationrescue therapyseizure clusters

Substanzen

DiazepamAnticonvulsantsKainic Acid

Autor:innen und Institutionen

  • Department of Pharmacy, Center for Epilepsy Drug Discovery, University of Washington, Seattle, Washington, USA.
  • Departments of Neurology and Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Neurelis, San Diego, California, USA.
  • John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
  • Center for Molecular Biology and Biotechnology, Charles E. Schmidt College of Science, Florida Atlantic University, Boca Raton, Florida, USA.

ORCID-Profile: Qian Wu, Michelle Guignet, H Steve White, Wesley T Kerr, Evelyn K Shih, Leock Y Ngo, Enrique Carrazana, Adrian L Rabinowicz

Förderung

  • Neurelis

Zitieren

APA

Wu, Q., Guignet, M., Vuong, J., White, H. S., Kerr, W. T., Shih, E. K., Ngo, L. Y., Carrazana, E., & Rabinowicz, A. L. (2026). Preclinical signal for a disease‐modifying effect on seizure cluster severity with intermittent diazepam treatment. Epilepsia. https://doi.org/10.1002/epi.70051

Vancouver

Wu Q, Guignet M, Vuong J, White HS, Kerr WT, Shih EK, et al. Preclinical signal for a disease‐modifying effect on seizure cluster severity with intermittent diazepam treatment. Epilepsia. 2026. doi:10.1002/epi.70051

BibTeX
@article{Wu2026,
  author = {Wu, Qian and Guignet, Michelle and Vuong, Jonathan and White, H Steve and Kerr, Wesley T and Shih, Evelyn K and Ngo, Leock Y and Carrazana, Enrique and Rabinowicz, Adrian L},
  title = {Preclinical signal for a disease‐modifying effect on seizure cluster severity with intermittent diazepam treatment},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70051}
}
Kostenlos starten →